Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and s-nitro-n-acetylpenicillamine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with s-nitro-n-acetylpenicillamine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(s-nitro-n-acetylpenicillamine)		Trials
(s-nitro-n-acetylpenicillamine)		Recent Studies (post-2010) (s-nitro-n-acetylpenicillamine)
9,15618755267722

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, DE; Klabunde, RE1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and s-nitro-n-acetylpenicillamine

ArticleYear
Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    European journal of pharmacology, 2000, Sep-22, Volume: 404, Issue:3

    Topics: Animals; Capillary Permeability; Cheek; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Penicillamine; Platelet Activating Factor; Vasoconstriction; Vasodilator Agents

2000